ABSTRACT SUBMISSION

Important Dates:

Abstract Submission is now open.

Abstract Submission Deadline
Monday, May 31, 2021

Extended to Monday, June 21, 2021

Notification of Acceptance
Extended to Tuesday, July 20, 2021

ISPE-ACPE13/KoPERM 28 in Seoul Korea, 13-15 October 2021 will be a hybrid scientific meeting allowing for either in-person, or online presentation of submitted research work.
Please read all information on this page before submitting your abstract.

Abstract Submission

Important Notes:

  • The first author listed for each abstract is considered to be the presenting author who will be the primary contact for all correspondence regarding the abstract.
  • Presenting authors are responsible for proofreading before submission. No edits will be allowed in submitted abstracts for typing, spelling, or grammatical errors.
  • Abstracts which are not correctly formatted will not be reviewed.
  • Abstracts must be submitted in English.

Presentation Types

Oral Presentation: 15 minutes (10 minutes for presentation and 5 minutes questions).

Option 1: Presenting in-person at the conference venue, COEX, Seoul.

Option 2: Presenting via a pre-recorded video and attending virtually for audience questions. This option is for presenters who are unable to travel to attend the conference. Consideration will be given to the country and location of speakers when scheduling them in the program.

The on-site technology will allow for both in-person and virtual attendees to ask questions of the presenters. Consideration will be given to the country and location of speakers when scheduling them in the program.

Poster Presentation:

Option 1: Presenting in-person from the conference venue, COEX, Seoul. In-person presenters will print an A0 (1189 mm high x 841 mm wide) size poster to display in the poster gallery and must be in attendance at their poster at a specific time to discuss with interested attendees. In-person presenters may also choose to submit an e-Poster presentation.

Option 2: Presenting an e-Poster via a 3-minute pre-recorded video with 3 PowerPoint slides. Pre-recorded e-Poster presentations will be available for conference delegates to view at their convenience through the conference website.

Spotlight Posters: For in-person presenters only.
A number of notable printed posters will be pre-selected for the Spotlight Poster Session. These poster presenters will be invited to deliver a 3-minute oral description of their work in English, followed by audience discussions moderated by a senior ISPE member. No slides can be used in describing the work, and the 3-minute time limit will be strictly enforced. Successful presenters will be notified on Wednesday, September 15, 2021.

Suggested Topics for Abstract Submission Are:

  1. A. Pharmaceutical policy and administration
  2. B. Pharmacoepidemiology and Pharmacovigilance research methods
  3. C. Drug safety risk monitoring, evaluation and prevention
  4. D. Pharmacogenomics research and drug safety
  5. E. Evidence-based medicine
  6. F. Evidence-based pharmacy
  7. G. Drug utilization evaluation studies
  8. H. Rational drug use
  9. I. Pharmacoepidemiology and traditional medicines
  10. J. Prevention of medication errors and drug misuse/abuse
  11. K. Rare disease and orphan medicines
  12. L. Post-marketing drug effectiveness and safety evaluation
  13. M. Prevention and treatment of drug-induced diseases
  14. N. Other related fields

Guidelines for Abstract Submission

Research abstracts are eligible, whether or not their content has been presented at meetings of other scientific societies, as long as they meet the following criteria:

  • relevant to the field of pharmacoepidemiology as broadly defined
  • results have not been published (except in abstract form) either on-line or in printed full form before January 1 of the year of the meeting, and
  • results have not been presented at a previous ISPE meeting.

Abstract Format

Abstract title: must not exceed 20 words.

Abstract text: must not exceed 300 words (excluding the Title, Authors, and Affiliations). Do not reference institution names, locations, or funding sources in the abstract.

Abstracts should include the following headings:

Aim/Objective:

Methods:

Results:

Conclusion:

Keywords: list not more than four keywords describing your research.

Graphics and tables cannot be submitted as part of your abstract.

Author Names and Affiliations:

Up to 15 authors and affiliations may be included on each abstract. All authors must have consented to the abstract submission.

Abstract Acknowledgement

You will receive an email acknowledging receipt of your abstract submission. If you do not receive this email and, after checking your spam/junk folder, please contact Expert Events via acpe@expertevents.com.au.

Abstract Review Process

All submitted abstracts will be reviewed by at least 3 reviewers.

In evaluating each abstract, reviewers will be unaware of authors or institutions involved with the work described in the abstract. (Abstracts will be suitably anonymised by the program secretariat before being sent out to reviewers).

The Program Committee will assign accepted abstracts either to oral or poster presentation, and the reviewers’ decision is final.

Notification of Acceptance

The Organising Committee reserves the right to accept or decline any submissions and to select the presentation format.

Presenting authors will be notified of their acceptance status on Tuesday, July 20, 2021 and must inform any co-author(s).

Presenter Registration

All presenting authors must have registered and paid to attend the conference by Wednesday, August 18, 2021.

Accepted abstracts will be published in the conference program only if the presenting author has registered for the conference.

Enquiries

All enquiries regarding abstracts and the submission process should be directed to the ACPE13 Program Secretariat, Expert Events.

Expert Events

PO Box 351, Hamilton Central QLD 4007 Australia

Tel: +61 7 3848 2100 | Email: acpe@expertevents.com.au